Figure 2.
Schema of common contributions and pathways from treatment to neurocognitive outcome in survivors of acute lymphoblastic leukemia treated on chemotherapy-only protocols. Chemotherapy agents affect vascular and central nervous system neurons and glia, which influence brain development. Neurocognitive dysfunction results from altered brain development as well as contributions from chronic health conditions.